Prediction of Survival in Resected Non–Small Cell Lung Cancer Using a Protein Expression–Based Risk Model: Implications for Personalized Chemoprevention and Therapy

dc.contributor.authorKathryn A. Gold
dc.contributor.authorEdward S. Kim
dc.contributor.authorDiane D. Liu
dc.contributor.authorPing Yuan
dc.contributor.authorCarmen Behrens
dc.contributor.authorLuisa M. Solis
dc.contributor.authorHumam Kadara
dc.contributor.authorDavid C. Rice
dc.contributor.authorIgnacio I. Wistuba
dc.contributor.authorStephen G. Swisher
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T14:12:34Z
dc.date.available2026-03-22T14:12:34Z
dc.date.issued2013
dc.descriptionCitaciones: 30
dc.description.abstractWe have developed a comprehensive risk model predictive for recurrence in our large retrospective database, which is one of the largest reported series of resected NSCLC.
dc.identifier.doi10.1158/1078-0432.ccr-13-1959
dc.identifier.urihttps://doi.org/10.1158/1078-0432.ccr-13-1959
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/45175
dc.language.isoen
dc.publisherAmerican Association for Cancer Research
dc.relation.ispartofClinical Cancer Research
dc.sourceUniversity of Saint Francis Xavier
dc.subjectImmunohistochemistry
dc.subjectMedicine
dc.subjectLung cancer
dc.subjectInternal medicine
dc.subjectOncology
dc.subjectProportional hazards model
dc.subjectCarcinogenesis
dc.subjectCancer
dc.subjectCancer research
dc.subjectPathology
dc.titlePrediction of Survival in Resected Non–Small Cell Lung Cancer Using a Protein Expression–Based Risk Model: Implications for Personalized Chemoprevention and Therapy
dc.typearticle

Files